"This is the first time we've seen improvement in fibrosis that was observed in participants with compensated cirrhosis due ...

Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

MASH faced an issue that almost no other sitcom has been able to overcome, but this ended up somehow making the classic ...

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

Target RWE, a leader in modern clinical evidence generation for complex diseases, today announced its presentations and strategic contributions at the EASL Congress 2025 in Amsterdam, Netherlands.

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Some have been standing there for over an hour. The band that’s worth the wait? Brass Mash. Aptly named, Brass Mash is a local SLO County all-brass instrument mash-up band. “It’s not a jazz ...